Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndrome.

Mielniczuk LM, Pfeffer MA, Lewis EF, Blazing MA, de Lemos JA, Shui A, Mohanavelu S, Califf RM, Braunwald E.

Am Heart J. 2008 Apr;155(4):725-31. doi: 10.1016/j.ahj.2007.11.031. Epub 2008 Feb 21.

PMID:
18371483
2.

Acute decline in renal function, inflammation, and cardiovascular risk after an acute coronary syndrome.

Mielniczuk LM, Pfeffer MA, Lewis EF, Blazing MA, de Lemos JA, Mohanavelu S, Rouleau J, Fox K, Pedersen TR, Califf RM.

Clin J Am Soc Nephrol. 2009 Nov;4(11):1811-7. doi: 10.2215/CJN.03510509. Epub 2009 Oct 9.

3.

Cystatin C and estimated glomerular filtration rate as predictors for adverse outcome in patients with ST-elevation and non-ST-elevation acute coronary syndromes: results from the Platelet Inhibition and Patient Outcomes study.

Akerblom Å, Wallentin L, Siegbahn A, Becker RC, Budaj A, Buck K, Giannitsis E, Horrow J, Husted S, Katus HA, Steg PG, Storey RF, Åsenblad N, James SK.

Clin Chem. 2012 Jan;58(1):190-9. doi: 10.1373/clinchem.2011.171520. Epub 2011 Nov 29.

4.

Prognostic impact of moderate renal dysfunction in acute coronary syndromes.

Nabais S, Rocha S, João C, Marques J, Torres M, Magalhães S, Pereira MA, Correia A.

Rev Port Cardiol. 2008 Mar;27(3):303-12; discussion 315-7.

5.

[Renal failure stages as predictors of mortality following acute coronary syndrome].

Sanchez Hidalgo A, Pou M, Leiro R, López Gómez D, Martínez Ruiz M, Saurina A, Esteve V, Fulquet M, Ramírez de Arellano M, de Miguel M.

Nefrologia. 2009;29(1):53-60. doi: 10.3265/Nefrologia.2009.29.1.53.1.en.full.pdf. Spanish.

6.

Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.

Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA.

N Engl J Med. 2004 Sep 23;351(13):1285-95.

7.

Do associations with C-reactive protein and extent of coronary artery disease account for the increased cardiovascular risk of renal insufficiency?

Zebrack JS, Anderson JL, Beddhu S, Horne BD, Bair TL, Cheung A, Muhlestein JB; Intermountain Heart Collaborative Study Group.

J Am Coll Cardiol. 2003 Jul 2;42(1):57-63.

8.

Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.

Sabatine MS, Morrow DA, Jablonski KA, Rice MM, Warnica JW, Domanski MJ, Hsia J, Gersh BJ, Rifai N, Ridker PM, Pfeffer MA, Braunwald E; PEACE Investigators.

Circulation. 2007 Mar 27;115(12):1528-36. Epub 2007 Mar 19.

9.

Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease.

Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, Seliger SL, Kestenbaum B, Psaty B, Tracy RP, Siscovick DS.

Ann Intern Med. 2006 Aug 15;145(4):237-46.

PMID:
16908914
10.

Concentrations of C-reactive protein and B-type natriuretic peptide 30 days after acute coronary syndromes independently predict hospitalization for heart failure and cardiovascular death.

Scirica BM, Cannon CP, Sabatine MS, Jarolim P, Sloane S, Rifai N, Braunwald E, Morrow DA; PROVE IT-TIMI 22 Investigators.

Clin Chem. 2009 Feb;55(2):265-73. doi: 10.1373/clinchem.2008.117192. Epub 2008 Dec 12.

11.

Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.

Eggers KM, Lagerqvist B, Venge P, Wallentin L, Lindahl B.

J Am Coll Cardiol. 2009 Jul 21;54(4):357-64. doi: 10.1016/j.jacc.2009.03.056.

12.

Prospective evaluation of pregnancy-associated plasma protein-a and outcomes in patients with acute coronary syndromes.

Bonaca MP, Scirica BM, Sabatine MS, Jarolim P, Murphy SA, Chamberlin JS, Rhodes DW, Southwick PC, Braunwald E, Morrow DA.

J Am Coll Cardiol. 2012 Jul 24;60(4):332-8. doi: 10.1016/j.jacc.2012.04.023.

13.

Usefulness of β-trace protein and cystatin C for the prediction of mortality in non ST segment elevation acute coronary syndromes.

Manzano-Fernández S, López-Cuenca A, Januzzi JL, Parra-Pallares S, Mateo-Martínez A, Sánchez-Martínez M, Pérez-Berbel P, Orenes-Piñero E, Romero-Aniorte AI, Avilés-Plaza F, Valdés-Chavarri M, Marín F.

Am J Cardiol. 2012 Nov 1;110(9):1240-8. doi: 10.1016/j.amjcard.2012.06.027. Epub 2012 Jul 19.

PMID:
22818840
14.

Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.

Ray KK, Cannon CP, Cairns R, Morrow DA, Ridker PM, Braunwald E.

Arterioscler Thromb Vasc Biol. 2009 Mar;29(3):424-30. doi: 10.1161/ATVBAHA.108.181735. Epub 2009 Jan 2.

15.
17.

Reduced glomerular filtration rate and its association with clinical outcome in older patients at risk of vascular events: secondary analysis.

Ford I, Bezlyak V, Stott DJ, Sattar N, Packard CJ, Perry I, Buckley BM, Jukema JW, de Craen AJ, Westendorp RG, Shepherd J.

PLoS Med. 2009 Jan 20;6(1):e16. doi: 10.1371/journal.pmed.1000016.

18.
19.
20.

Comparison of renal function and cardiovascular risk following acute myocardial infarction in patients with and without diabetes mellitus.

Anavekar NS, Solomon SD, McMurray JJ, Maggioni A, Rouleau JL, Califf R, White H, Kober L, Velazquez E, Pfeffer MA.

Am J Cardiol. 2008 Apr 1;101(7):925-9. doi: 10.1016/j.amjcard.2007.11.037.

PMID:
18359309

Supplemental Content

Support Center